Under the term sheet, CRML will receive long-term offtake rights to 50% of the Tanbreez concentrate output and set out plans ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Voyager's robust $413M cash balance and minimal debt mitigate near-term financing risk despite negative EBITDA and net losses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback